logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
14/05/2025
Lifemore Securities shows that Nobicon Artificial Intelligence Technology Co., Ltd. has submitted an application for listing on the Hong Kong Stock Exchange, with China International Capital Corporation Limited as the exclusive sponsor.
Latest
3 m ago
Raymond James: Maintains Allogene Therapeutics (ALLO.US) rating from Outperform to Strong Buy, with a target price changed from $10.00 to $9.00.
3 m ago
Bank of America: Maintains UnitedHealth Group (UNH.US) rating, adjusting from buy to hold rating, with a target price adjustment from $677.00 to $351.00.
3 m ago
Neuralink: The PRIME trial in the UAE explores how patients with movement and speech disorders can use thought-controlled devices for communication.
4 m ago
Uber and Volkswagen will launch autonomous driving services in Los Angeles, USA in early 2026.
4 m ago
Market news: Elon Musk's brain-machine interface company Neuralink has launched the first clinical trial in the Middle East region at a clinic in Abu Dhabi's Cleveland.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.